Effects of psychopharmacotherapy on phenotypic expression of cytochrome P450 2D6 in patients genotyped for CYP2D6 mutations

被引：0
|
作者：
Zelenkáv, O [1 ]
Hadsová, E
Cesková, E
Vojtísková, M
Hyksová, M
机构：
[1] Masaryk Univ, Fac Med, Dept Pharmacol, CS-60177 Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Psychiat Clin, CS-60177 Brno, Czech Republic
[3] Masaryk Univ, Fac Med, Dept Biochem, CS-60177 Brno, Czech Republic
[4] JG Mendel Fac Childrens Hosp, Dept Med Genet, Brno, Czech Republic
来源：
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 2000年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：303 / 305
页数：3
相关论文
共 50 条
  • [11] The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients
    Topic, E
    Stefanovic, M
    Ivanisevic, AM
    Petrinovic, R
    Curcic, I
    CLINICA CHIMICA ACTA, 2000, 296 (1-2) : 101 - 109
  • [12] Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
    Bezerra, Lucas Soares
    Oliveira Santos-Veloso, Marcelo Antonio
    Bezerra Junior, Natanael da Silva
    da Fonseca, Lucilia Carvalho
    Andrade Sales, Wivianne Lisley
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2018, 40 (12): : 794 - 799
  • [13] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [14] Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin
    Haritos, VS
    Ghabrial, H
    Ahokas, JT
    Ching, MS
    PHARMACOGENETICS, 2000, 10 (07): : 591 - 603
  • [15] Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
    Ingelman-Sundberg, M
    PHARMACOGENOMICS JOURNAL, 2005, 5 (01): : 6 - 13
  • [16] Persistent mood disorders and cytochrome P450 2D6:: influence of the CYP2D6 gene duplication on the development of persistence
    Kawanishi, C
    Ågren, H
    Bertilsson, L
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 180 - 180
  • [17] Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding
    Wang, An
    Stout, C. David
    Zhang, Qinghai
    Johnson, Eric F.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (08) : 5092 - 5104
  • [18] Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity
    Magliocco, Gaelle
    Desmeules, Jules
    Matthey, Alain
    Quiros-Guerrero, Luis M.
    Bararpour, Nasim
    Joye, Timothee
    Marcourt, Laurence
    Queiroz, Emerson F.
    Wolfender, Jean-Luc
    Gloor, Yvonne
    Thomas, Aurelien
    Daali, Youssef
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (23) : 4708 - 4725
  • [19] The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence on clinical outcomes in psychiatry
    Chen, SQ
    Chou, WH
    Blouin, RA
    Mao, ZP
    Humphries, LL
    Meek, C
    Neill, JR
    Martin, WL
    Hays, LR
    Wedlund, PJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (05) : 522 - 534
  • [20] Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
    M Ingelman-Sundberg
    The Pharmacogenomics Journal, 2005, 5 : 6 - 13
12345